Reappraisal of Histologic Features of the Acute Cutaneous Graft-Versus-Host Reaction Based on an Allogenic Rodent Model  by Horn, Thomas D et al.
Reappraisal of Histologic Features of the Acute 
Cutaneous Graft-Versus-Host Reaction Based 
on an Allogeneic Rodent Model 
Thomas D. Horn, Diane J. Bauer, Georgia B. Vogelsang,* and Alan D. Hess* 
Departments of Dermatology and · Oncology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, U .S.A. 
We employed a rat model of complete major histocompati-
bility complex-mismatched allogeneic bone marrow trans-
plantation to better characterize the histologic expression of 
the acute cutaneous graft-versus-host reaction (GVHR), 
compared with changes due to the preparative regimen. Cy-
closporin A abolished the development of this GVHR. Low 
levels of dyskeratotic cells were present in all groups (allo-
geneic and syngeneic transplants with and without cyclo-
sporin A) and, alone, were insufficient to diagnose a cutane-
ous GVHR. A consistent histologic feature of the GVHR was 
significant lymphoid infiltration of the dermis. The pattern 
of cytotoxic folliculitis involved follicular epithelium above 
the entry of sebaceous glands. lmmunostain for major histo-
compatability complex class II, lA, and IE antigens revealed 
T he histologic criteria diagnostic of the human acute cutaneous graft-versus-host reaction (GVHR) were established by Lerner et al in 1974 [1]. The features identified included vacuolar alteration of the basilar epidermis (grade 1), vacuolar alteration plus spongio-
sis and dyskeratosis of epidermal keratinocytes (grade 2), subepider-
mal cleft formation (grade 3), and loss of epidermis (grade 4). 
Confident discrimination between histologic changes of graft-ver-
sus-host disease (GVHD) and changes due to the preparative regi-
ment can be difficult [2-4]. 
Since the initial histologic description of the acute cutaneous 
GVHR, the field of bone marrow transplantation has witnessed 
many significant advances; among these is the prophylactic admin-
istration of cyclosporin A (CSA) to avert the often lethal sequelae of 
fully evolved GVHD . The histologic features delineated above 
continue to be employed to establish the diagnosis of an acute cuta-
neous GVHR despite intrathymic and peripheral modification of 
immunologic events due to CSA therapy. To what extent this im-
munomodulation alters the diagnostic reliability 'of the standard 
grading scheme is unknown. 
In an earlier work, we showed that the best predictors of the 
development of progressive and fatal human acute GVHD were 
peak values within the first 100 d of allogeneic marrow transplant 
for total bilirubin, stool volume in a day, clinical stage of cutaneous 
GVHD (based on extent of rash), and 'overall clinical stage of 
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that dendritic cells within the follicle were limited to this 
upper region and that lower follicular epithelium did not 
upregulate expression with evolution of the GVHR. Based 
on this model, we conclude 1) that the diagnostic scheme for 
the acute cutaneous GVHR should include lymphoid infil-
tration of the dermis, 2) that the preparative regimen (in-
cluding total body irradiation) induces persistent low levels 
of dyskeratotic cells (two to three cells/linear mm of epider-
mis), and 3) that the pattern of follicular involvement may 
relate to the distribution of dendritic cells and to an inability 
of lower follicular epithelium. to upregulate major histocom-
patability complex class II antigens. Key words: tral1splal1ta-
tion/cyclosporil1/immullology. ] Jm/est Dermatol 103:206 - 210, 
1994 
GVHD (based on the combination of GVHRs in the skin, liver, and 
gastrointestinal tract) [4]. No skin biopsy parameter or combination 
of parameters provided useful prognostic information in our study. 
We wished to characterize and quantify epidermal and follicular 
patterns of keratinocytic dyskeratosis as it is this finding, in particu-
lar, which establishes diagnostic Grade 2 changes and which is 
highly variable numerically. Additionally, we sought histologic 
findings not included in the present grading scheme that might aid 
in the differentiation between nonspecific or preparative regimen 
changes and a true GVHR .. 
MATERIALS AND METHODS 
Lewis and ACI, virns-frec, fema le rats, 6 -10 weeks old, were purchased 
from Charles River, Wilmington, MA. 
Preparative Regimen Lewis rats served as the recipients in all groups. 
Recipients were given 60 mg/kg cyclophosphamide by intraperitoneal in-
jection 2 d prior to marrow infusion. The next day, Lewis rats were irra-
diated (1050 rad) at 120 rad/min from a dua l-source mCs small animal 
irradiator (Atomic Energy of Canada Ltd., Kanata, Ontario, Canada). This 
regimen was chosen to provide analogy to human bone marrow transplants. 
Marrow'Transplantation Donor animals were killed by CO2 asphyxia-
tion. Marrow from femurs, tibias, and humeri was collected in Hanks' solu-
tion supplemented with 50 U/ml penicillin and 50 tlg/ml streptomycin. 
The marrow cells were adjusted to a concentration of 6 X 107 nucleated 
cells/ml and 1 111.1 was infused into recipient animals by intravenous injection 
into the tail vein 1 d after irradiation. 
Antibiotics Rats received medicated drinking water supplemented with 
bactrim, neomycin, and polymyxin B. 
Cyclosporin CSA was the generous gift of Sandoz, Ltd., Basel, Switzer-
land. The powdered CSA was dissolved in 95% ethanol and added to a 4% 
Tween-20 solution in deionized water. Rats were weighed daily and re-
ceived 100 mg/ml/d subcutaneously from the day of marrow infusion and 
for 24 consecutive days. The total dose of CSA per day per rat was 12.5 
mg/kg. Given pharmacokinetic differences between rats and humans, we 
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Table I. Scheme of Transplantation 
Group 
• Five rats pcr group. 
1 
2 
3 
4 
Recipient 
Lewis' 
Lewis 
Lewis 
Lewis 
Donor 
Lewis 
ACI 
Lewis 
ACI 
feel that this dose is equivalent to the standard initial human dose of 5 
mg/kg/d. Only rats in groups 3 and 4, as noted in Table I, received CSA. 
Assessment of GVHD Rats were examincd daily for signs of clinical 
GVHD, such as red ears, dermatitis, or diarrhea. Skin biopsies wcre takcn on 
days 0, 7, 12, 19, and 23 of marrow transplantation. Care was takcn to avoid 
sampling near skin inflamed due to prior biopsy trauma. Skin from the back 
was samplcd at each timepoint in approximately the same location on the 
back for each animal. Rats were anesthetized with mctaphane before each 
procedure. Animals were cuthanized on day 24 by CO2 asphyxiation. 
Histologic Assessment Each skin biopsy was divided, with half placcd in 
10% formalin and half placed in a phosphate-buffered saline solution for 
24 h (4 'C) prior to cryopreservation at -70'C. Formalin-fixed tissue was 
cut and stained with hematoxylin and eosin. Tissue was analyzed for 1) 
presence of mononuclear cell infiltrate of the dermis (+ or -),2) vacuoliza-
tion of the basdar cpldenms (+ or -), and 3) dyskeratosIs of cpldermal and 
follicular ceJls (number of dyskeratotic ceJls/linear mm of epidermis and + 
or - in follicular epithelium). Frozen tissue was analyzed for expression of 
the major histocompatability complex (MHC) class II antigcns IA (MCA46) 
and IE (MCAsO); both IgG, isotype. The monoclonal antibodies were ob-
tained from Harlan Bioproducts for Science, Indianapolis, IN. Immuno-
staining was performed using standard immunoperoxidasc techniques [5]. 
One specimen from each group was staincd using mouse anti-rat CD4 of the 
IgG, isotype as a control. Antibody complexes wcre visualized using diami-
nobenzidine. Semiquantitative analysis was performed simultancously by 
twO observers (TDH and DJB), in a blindcd fashion. 
RESULTS 
The scheme of transplantation is outlined in Table I. Animals in 
group 2 surviving to day 23 were near death. The predominant 
clinical manifestation of GVHD in the animals was generalized 
erythroderma. Weight loss, diarrhea, and failure to thrive were also 
noted. Rats in the other groups, with the exception of the one 
animal mentioned below, showed no clinical signs of disease. One 
rat from each of groups 1,3, and 4 was killed during the course of 
the experiment due to failure to engraft the transplanted marrow. 
The histologic data are summarized in Table II. The features 
included a mononuclear cell infiltrate in the dermis with mild exo-
cytosis of lymphoid cells into epidermis and follicular epithelium, 
dyskeratotic cells within the epidermis and follicular epithelium, 
and vacuolization of the basilar epidermis and follicular epithelium 
(Fig. 1). Follicular involvement was particularly noteworthy in that 
the histologic changes described above occurred only in epithelium 
above the level of entry of the sebaceous gland into the follicle (Fig 
1). The inflammation was distributed uniformly around the upper 
follicle. Localization of changes to a more specific anatomic portion 
of the upper follicular epithelium, such as the bulge area, was not 
observed despite serial sectioning of the tissue. No histologic 
change attributable to GVHD was observed in samples from other 
animals. The apposition of a lymphocyte to a dyskeratotic epider-
mal cell, i.e., satellitosis, was occasionally observed in tissues with a 
significant lymphoid infiltrate. 
Beginning with the first specimens taken at day 7, scattered dys-
keratotic follicular cells were observed in the region of the bulb in 
all groups. These eosinophilic, shrunken cells were not present in 
association with a lymphoid infiltrate. Dyskeratotic cells in this 
location were observed in other specimens from all groups, in low 
number, at each subsequent timepoint. Significant spongiosis was 
not observed. Keratinocytic dysmaturation (loss of normal progres-
sion from cuboidal basilar keratinocyte to flattened squame in the 
stratum spinosum) consistent with the effects of cell cycle arrest due 
to cyclophosphamide was present in all specimens after day 7. Ca-
CSA Transplant Type 
None Syngeneic unmodified 
None Allogeneic unmodified 
12.5 mg/kg/d Syngeneic CSA 
12.5 mg/kg/d Allogeneic CSA 
sual observation suggested that a reduction in anagen follicles oc-
curr.ed, as r~ported previously by Murphy et al [6]. By day 23, regen-
eratl11g folhcles were observed extending downward from telogen 
phase follicular epithelium. 
Immunostain to rat IA and IE class II MHC epitopes was per-
for.med. Tissue ta~en on day 0 displayed the expected pattern of 
staml11g. End<:>th~ltal cells and dendritic cells of the epidermis, folli-
cle, and dermiS displayed both antigens. The microanatomy of den-
dritic cells in follicular epithelium was interesting in that positively 
stamed cells were confined to the portion of the follicle above the 
entry of sebaceous glands (Figs 2, 3). Specimens from animals in 
groups 1, 3, and 4 revealed a similar pattern of class II MHC distri-
bution at all timepoints, except in the one rat expressing a GVHR on 
day 19 in group 4. This animal experienced the sudden onset of 
GVHD as an apparent breakthrough of the immunosuppression of 
CSA. In isotype control tissues, staining was confined to the cell 
membranes of lymphocytes and various dendritic cells. Whereas a 
decrease in dendritic cell number was observed, these cells were 
identified in epidermis and follicle at all timepoints in control tissue. 
A higher concentration of dendritic cells in follicular epithelium 
than in epidermis was not noted . The histologic expression of 
GVHD (group 2) was accompanied by upregulation of IA and IE 
antigens on epidermis and follicular epithelium. In tissue with a 
GVHR, epithelial upregulation ofIA and IE prevented the identifi-
cation of dendritic cells. Basal layer cells stained more intensely and 
uniformly than epithelial cells at higher levels (Fig 4). Staining of 
follicular epithelium was not present at all levels; rather, upregula-
tion ofIA and IE was observed in the bulb, above the level of entry of 
sebaceous glands and around sebaceous glands (Figs 5, 6). This pat-
tern was noted in tissue from early and late stages of the develop-
ment of GVHD and occurred 111 estabhshed anagen follicles. Prior 
work (unpublished observations) has shown that the ACI > Lewis 
combination results in a dermal infiltrate of CD4+ and CD8+ cells 
with CD8+ cells predominating in the epidermis. 
DISCUSSION 
We employed a rat model of allogeneic bone marrow transplanta-
tion to assess temporal changes in cutaneOllS histology referable to 
GVHD versu~ preparat~v~ regiment (total body irradiation and cy-
clophosphaUllde). In cltmcal practice, this distinction is important 
because therapeutic decisions are often based upon the outcome of 
skin biopsy specimen interpretation. Mild histopathologic changes 
are frequently observed and are of questionable value in patient 
management. Quantification of dyskeratosis and identification of 
other diagnostic elements might increase the specificity of the 
scheme currently employed. 
The results of our study in a rat model of allogeneic GVHD show 
that CSA abolishes the expression of histologic features of the aCllte 
cutaneous GVHR. Two specific histologic findings in rats develop-
l11g GVHD deserve special mention. First, a GVHR was not ob-
served in the absence of lymphoid infiltration of the dermis. The 
criteria currently employed for the tissue diagnosis of the human 
acute cutaneous GVHR include mononuclear inflammation in the 
grading scheme as a confirmatory finding [7). We propose that the 
diagnosis of a human acute cutaneous GVHR is dependent on the 
presence of a mononuclear cell infiltrate in the dermis as a minimum 
criterion with exocytosis into epidermis or follicular epithelium as a 
corroborating finding. The current system should be modified to 
include dermal lymphocytic infiltrate as a requirement for Grade 2 
changes (Table III). Much experimental evidence supports the con-
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Table II. Summary of the Histologic Data 
Average Number of 
Number of Dyskeratotic Epidermal Cells/ Lymphocytic Vacuolization of Involvement of 
G~oup Day Animals Linear mm of Epidermis Infiltrate Basilar Epidermis Upper Follicle 
l' 7 5 0 
1 12 4 1.25 
1 19 4 0.75 
1 23 4 0.25 
2' 7 5 0.6 
2 12 5 6 +(5/5)' +(5/5) +(4/5) 
2 19 5 2.8 +(5/5) +(5/5) +(5/5) 
2 23 5 0.4 +(5/5) +(5/5) 
3d 7 5 0 
3 12 5 3.25 
3 19 4 0.75 
3 23 4 0 
4' 7 5 0.2 
4 12 4 3.25 
4 19 4 2.5 
4 23 4 
• 1, syngeneic, unmodified. 
• 2, allogeneic, unmodified. 
, Number in parentheses, number of specimens showing feature/total number of specimens. 
J 3, syngeneic with CSA. 
, 4, allogeneic with CSA. 
cept of GVHD as an immunologic disease mediated by lympho-
cytes. It is possible that cytokines (e .g., tumor necrosis factor-alpha) 
play a significant role in mediating epidermal damage and thus 
lymphocytes present in the epidermis may not be a requirement. To 
what extent CSA diminishes the lymphoid infiltrate in a human 
GVHR is not clear. The consistent finding of lymphocytes in 
human epidermis during GVHD has been noted [8]. 
Second, we observed low number of dyskeratotic cells in epider-
mis and follicular epithelium without mononuclear inflammation 
in control groups (syngeneic transplant groups), suggesting that 
dyskeratosis is a process partly attributable to preparative regimen. 
This observation in human skin biopsy specimens was first reported 
by Sale et al [9], yet a possible quantitative difference in dyskeratosis 
Figure 1. Skin from rat in group 2, day 12. The acute cutaneous GVHR 
involves epidermis and follicular epithelium above the sebaceous gland. 
Outer sebaceous epithelium displays exocytosis oflymphocytes. Hematoxy-
lin and eosin; bar, 100 J.l. 
between the cytotoxic effect of the preparative regimen and a 
GVHR has not been explored. The practical extension of our data to 
human disease lies in the common clinical situation in which a 
diagnosis of an acute cutaneous GVHR is rendered in tissue with 
minimal or no inflammation and few dyskeratotic cells. Our find-
ings suggest that two or three dyskeratotic cells per linear mm of 
epidermis, in the absence of a lymphoid infiltrate, are insufficient to 
establish the diagnosis of a GVHR. 
The cytotoxic folliculitis of GVHD is well recognized [10] . 
Murphy et al postulate that follicular targeting of GVHD effector 
cells may arise due to the presence of pluripotent "stem" cells in the 
bulge region of the upper follicle [6]. Our data from immunostain-
ing for MHC class II, lA, anJ:\ IE antigens would suggest that target-
ing of upper follicular epithelium in rats relates to the limited distri-
bution of dendritic cells within the follicl e above the entry of 
sebaceous glands or an inability of follicular keratinocytes in lower 
portions of the follicle to upregulate IA and IE antigens in response 
to the cytokines secreted by infiltrating mononuclear cells causing 
the acute cutaneous GVHR. 
Figure 2. Skin from rat in group 1, day 12. Dendritic cells expressing IE are 
present in the epidermis and upper follicle (arrows). No GVHR developed in 
this control animal. Immunostain with diaminobenzidine; bar, 100)1.. 
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Figure 3. Skin from rat in group 1, day 12. Follicular epithelium below the 
sebaceous glands from the same follicle in Fig 3 does not contain dendritic 
cells expressing IE. Note adjacent, positively stained, dermal dendrocytes 
(arrows) . Immunostain with diaminobenzidine; bar, toO /.t . 
Preparative regimen is known to alter epidermal Langerhans cell 
morphology, number, and function in humans and rodents [11-
13]. In a murine model of allogeneic GVHD, the allostimulatory 
capacity as well as the ability to present proteins to antigen specific T 
cells by host epidermal cells decreased with loss of Ia+ cells due to 
ionizing radiation [14] . An additional incremental loss in these 
functions was noted in the presence of GVHD. These findings 
suggest the possibility that Langerhans cells are early targets of 
GVHD effector cells. Our observation ofIa+ dendritic cells limited 
to upper follicular epithelium might correlate the limited pattern of 
cytotoxic folliculitis with targeting of Langer hans cells in the acute 
cutaneous GVHR. Effector cell interactions with Langerhans cells 
may occur before clinical expression of the GVHR; serial skin 
biopsy specimens from normal skin may show grade 2 changes in 
advance of the cutaneous eruption [7]. 
To what extent the data accrued in this study may be extrapolated 
to human marrow transplants is uncertain. The rat strains employed 
provided a complete MHC mismatch. Human transplants are 
mostly performed between MHC-concordant individuals, but one 
and rarely two antigen-mismatched marrow transplants are under-
Figure 4. Skin from rat in group 2, day 
12. A) Upregulation ofIA on epidermal 
keratinocytes is seen at lower epidermal 
levels. B) Isotype control using mono-
clonal antibody (IgG,) to rat CD4 does 
not stain keratinocytes. ImmUllostaill 
wi th diamillobenzidine; bar, 10/.t. 
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taken. It is possible that histologic features of GVHD are expressed 
to a greater or lesser degree in humans receiving CSA. We specifi-
cally chose to study the early course of GVHD to investigate time-
points covering the average onset of acute GVHD in humans, 
roughly 17 d posttransplant based upon our experience. At later 
timepoints, the distinction between pathologic changes referable to 
preparative regimen versus GVHD becomes easier. Prospective 
study in human tissues will be required to establish the utility of 
these observations in the management of bone marrow transplant 
(BMT) patients. 
The possibilities that the observed lymphocytic infiltration of the 
skin represent an artifact of a model employing complete MHC 
mismatch or a secondary phenomenon after established tissue dam-
age are unlikely. First, lymphocytic infiltration of the skin as part of 
the GVHR is a consistently reported finding in studies of rodent 
BMTs between strains mismatched only for minor transplantation 
antigens [15-17]. Both C3H.SW-+B6 and BlO.D2-+DBA/2 
strain combinations have been shown to produce cutaneous lymph-
oid infiltrates as part of the cutaneous GVHR [15] . In fact, the 
degree of mononuclear cell infiltration corresponds to the numbers 
of dyskeratotic cells per mm, as well as to the degree of basal layer 
vacuolar alteration [15] . Earlier observations of BMT across minor 
antigen mismatch detail the timecourse of mononuclear infiltration 
of the cutaneous tissues during GVHD, noting inflammatory cell 
accumulation beginning in the second week after BMT, with in-
creasing numbers of cells over time [16]. This timecourse parallels 
the observations noted here. Second, if lymphocytic infiltration of 
the skin were merely an effect of skin tissue danlage mediated by 
another mechanism (e.g., preparative regimen), we would have an-
ticipated finding significant inflammation in skin specimens from 
control animals. Therefore, whereas the degree of inflammation 
may vary, lymphocytic infiltration is an intrinsic component of the 
acute cutaneous GVHR, whether in MHC-concordant or -discor-
dant transpl;1l1ts. 
Our earlier retrospective study [4] concluded that cutaneous his-
tologic findings were not prognostic for the course of GVHD or 
BMT outcome. We were unable to make conclusions regarding the 
diagnostic accuracy of the histologic scheme, as a lethally irradiated 
but nontransplanted human control population does not exist. The 
present study was designed to investigate whether specific histo-
logic findings had diagnostic, not prognostic value. As such, the two 
studies are not directly comparable. Although lymphocytic infiltra-
tion of the skin in the earlier study did not have predictive value, this 
finding may still provide significant diagnostic value, particularly in 
discerning changes due to preparative regimen from a true GVHR. 
In human skin, examples of epidermal damage not immunologi-
cally mediated include acute ionizing radiation changes, phototoxi-
city, and certain toxic drug reactions. Examples of disease with 
inmmnologically mediated epidermal damage include lichen planus 
(the cytotoxic folliculitis of lichen planopilaris is analogous to the 
rodent model described here), lupus erythematosus, paraneoplastaic 
pemphigus, and skin graft rejection. It is the presence and pattern-
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Figure 5. Skin from rat in group 2, day 19. Upregnlation of IA on upper 
follicular epithelium, sebaceous epithelium, and follicular bulb is evident. 
Epithelium between the sebaceous gland and bulb lacks expression of IA. 
Immunostain with diaminobenzidine; bar, 100/1. 
ing oflymphocytes in cutaneous tissues in the latter group that serve 
to distinguish immune-mediated epidermal damage from damage 
referable to external physical factors. It is precisely this distinction 
that should be employed in the diagnosis of the cutaneous GVHR, 
especially in the differentiation from toxic effects of the preparative 
regimen. 
Based upon these observations, we conclude 1) that the require-
ments for the diagnosis of Grade 2, acute cutaneous GVHR changes 
should be modified to include a mononuclear infiltrate in the 
dermis, 2) that low numbers of dyskeratotic cells within the epider-
mis (two to three cells/linear mm) and follicle relate to the prepara-
tive regimen, and 3) that cytotoxic folliculitis of rodent acute cuta-
neous GVHR involves follicular epithelium above the level of entry 
of sebaceous glands because of the distribution pattern of dendritic 
cells or an inability to upregulate MHC class II antigens on lower 
Figure 6. Omission of primary antibody serves as negative control for 
comparison with Fig 5. Hematoxylin counterstain; bar, 100/1. 
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Table III. Proposed Scheme for Histologic Diagnosis of the 
Acute Cutaneous GVHR 
Grade 1 
Grade 2 
Grade 3 
Grade 4 
Vacuolar alteration of basilar epidermis 
Vacuolar alteration, dyskeratotic epidermal and fol-
licular cells," dermal lymphoid infiltrate 
Subepidermal cleft formation 
Loss of epiderm is 
• > 2 to 3 dyskeratotic cells/linear mm of epidermis or follicular epithelium. 
follicular epithelium. Application of the first two conclusions to the 
interpretation of tissue ta.ken to diagnose the human acute cutane-
ous GVHR may result in improved specificity. The last conclusion 
leads to the speculation that an epitope(s) on the class II MHC 
molecule serves as the target for GVHD effector cells generated in 
this rat model. This possibility is postulated for the CSA-induced 
syngeneic GVHD in the Lewis rat [18]. If true, blocking of the 
recognition site(s) on the molecule might result in a useful strategy 
for therapeutic intervention. 
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